State Street Corp Biond Vax Pharmaceuticals Ltd. Transaction History

State Street Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.15 - $2.34 $97,958 - $199,323	-85,181 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.48 - $2.92 $8,496 - $16,763	5,741 Added 7.23%	85,181 $200,000
Q3 2021 Nov 15, 2021	SELL	$2.15 - $3.44 $1,399 - $2,239	-651 Reduced 0.81%	79,440 $175,000
Q2 2021 Aug 16, 2021	BUY	$2.6 - $3.91 $5,668 - $8,523	2,180 Added 2.8%	80,091 $230,000
Q1 2021 May 17, 2021	BUY	$3.1 - $5.95 $21,080 - $40,460	6,800 Added 9.56%	77,911 $296,000
Q4 2020 Feb 16, 2021	BUY	$2.5 - $40.97 $136,555 - $2.24 Million	54,622 Added 331.26%	71,111 $200,000
Q3 2020 Nov 10, 2020	BUY	$23.7 - $51.1 $390,789 - $842,587	16,489 New	16,489 $645,000

Ticker BVXV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,678,800
Market Cap $12M
Description
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.